RSV vaccine use – the missing data

Simon B. DrysdaleOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK;NIHR Oxford Biomedical Research Centre, Level 2, Children’s Hospital, Oxford, UK

Charles J. SandeOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK

Christopher A. GreenOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK

Andrew J. PollardOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK;NIHR Oxford Biomedical Research Centre, Level 2, Children’s Hospital, Oxford, UKCorrespondence[email protected]

ABSTRACT

Respiratory syncytial virus (RSV) infection is the most important cause of hospitalization in infants and is one of the leading global causes of infant mortality and as such its prevention through vaccination is a public health priority. While essential for the successful implementation of vaccine programs, there remains a paucity of data on the epidemiology of the virus in different settings and age groups and limited knowledge about virus transmission and the health-care costs of the disease. Such data are now needed to populate health economic models and to inform optimal approaches to disease control through vaccination.

KEYWORDS:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

RSV vaccine use – the missing data

Information for

Open access

Opportunities

Help and information

RSV vaccine use – the missing data

ABSTRACT

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature